Amryt Pharma is quoted on the London Stock Exchange’s AIM Market and the Irish Stock Exchange’s Euronext Market.

Major Shareholders

Major shareholders

Major shareholders are as follows (interest as at 24 September 2019).

Name Number of shares % of issued share capital
Funds managed by Athyrium
Capital Management, LP
42,883,097 27.2%
Novelion Therapeutics Inc. 14,040,250 8.9%
Funds managed by Highbriidge
Capital Management, LLC
12,903,055 8.2%
Software AG-Stiftung
Funds managed by UBS
O’Connor LLC
8,584,830 5.4%
AXA Investment Management 6,494,164 4.1%

There are a total of 157,718,438 shares in issue and no shares held in treasury. Pursuant to the AIM Rules, and insofar as the Company is aware, as at 24 September  2019, 31.25% of the Company’s AIM securities were not in public hands.

Restrictions: there are no restrictions on the transfer of Ordinary Shares.
Takeover Code: the Company is subject to the City Code on Takeovers and Mergers.